During the past decade, Szpital Uniwersytecki w Krakowie, Oddział Kliniczny Kliniki Onkologii conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 14 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 11 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Uniwersytecki w Krakowie, Oddział Kliniczny Kliniki Onkologii" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator and "Institut de Recherches Internationales Servier" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Szpital Uniwersytecki w Krakowie, Oddział Kliniczny Kliniki Onkologii" are "Breast Cancer" (6 trials), "Colorectal Cancer" (2 trials), "Malignant Melanoma" (2 trials), "Breast Neoplasms" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Szpital Uniwersytecki w Krakowie, Oddział Kliniczny Kliniki Onkologii" in a lesser frequency.

Most popular intervention types in "Szpital Uniwersytecki w Krakowie, Oddział Kliniczny Kliniki Onkologii" are "Drug" (22 trials), "Other" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (10 trials), "Placebo" (8 trials), "Paclitaxel" (7 trials), "Pertuzumab" (7 trials) and "Trastuzumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Szpital Uniwersytecki w Krakowie, Oddział Kliniczny Kliniki Onkologii" are 21 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Szpital Uniwersytecki w Krakowie, Oddział Kliniczny Kliniki Onkologii". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Szpital Uniwersytecki w Krakowie, Oddział Kliniczny Kliniki Onkologii, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Szpital Uniwersytecki w Krakowie, Oddział Kliniczny Kliniki Onkologii, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".